Chantelle L Ahlenstiel
Dr. Ahlenstiel is a Senior Research Fellow at the Kirby Institute, UNSW, where she leads the RNA Silencing Group. Her research group develops antiviral RNA therapeutics to silence virus infections. Originally focused on HIV-1, this approach has now expanded to include development of RNA therapeutics targeting other virus infections, including Coronaviruses, SIV, HPV, EBV and HTLV-1.
Abstracts this author is presenting:
